Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Riluzole increases glutamate uptake by cultured C6 astroglial cells.
At Four Years, Treatment Effect Maintained in More Than Two-Thirds of Patients Who Received Genzyme’s Lemtrada in Pivotal Studies
Impact of Depression, Fatigue and Disability on Quality of Life in Chinese Patients with Multiple Sclerosis.
[Chronically Ill and Unemployed? A Review on Vocational Status in Multiple Sclerosis].
The refinement of genetic predictors of multiple sclerosis.
Increase in the prevalence of multiple sclerosis over a 17-year period in Osona, Catalonia, Spain.
Lack of response to pulse cyclophosphamide in neuromyelitis optica: evaluation of 7 patients.
Pharmacodynamics, pharmacokinetics, and safety of multiple doses of FTY720 in stable renal transplant patients: a multicenter, randomized, placebo-controlled, phase I study.
MR imaging findings of the corpus callosum region in the differentiation between multiple sclerosis and neuromyelitis optica.
Multiple sclerosis.
Topographical and Biological Evidence Revealed FTY720-Mediated Anergy-Polarization of Mouse Bone Marrow-Derived Dendritic Cells In Vitro.
Potential Role of Glucagon-Like Peptide-1 (GLP-1) in Neuroprotection.
Amelioration of experimental autoimmune encephalomyelitis by anatabine.
Magnetic Resonance Spectroscopy to Assess NeuroInflammation and Neuropathic Pain.
Ongoing Oxidative Stress Causes Subclinical Neuronal Dysfunction in the Recovery Phase of EAE.
Natalizumab treatment shows no clinically meaningful effects on immunization responses in patients with relapsing-remitting multiple sclerosis.
Causes of Death among Commercially Insured Multiple Sclerosis Patients in the United States.
Tumefactive MS lesions under fingolimod: A case report and literature review.
Association between pathological and MRI findings in multiple sclerosis.
Quantitative Evaluation of BAFF, HMGB1, TLR 4 AND TLR 7 Expression in Patients with Relapsing Remitting Multiple Sclerosis.
Effects of phenytoin on the persistent Na+ current of mammalian CNS neurones.
Interferon Beta Use and Disability Prevention in Relapsing-Remitting Multiple Sclerosis.
Polyunsaturated fatty acids in multiple sclerosis therapy.
Distinct serum cytokine profiles in neuromyelitis optica and multiple sclerosis.
Role of the renin-angiotensin system in autoimmune inflammation of the central nervous system.
Pages
« first
‹ previous
…
197
198
199
200
201
202
203
204
205
…
next ›
last »